Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis

Objective: The objective of this study was to assess the effect of treatment with interferon (IFN) β-1a, 44 µg subcutaneously (sc) three times weekly (tiw), on clinical and magnetic resonance imaging (MRI) outcomes in patients with relapsing multiple sclerosis (MS) following mitoxantrone therapy. Me...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rieckmann, Peter, Heidenreich, Fedor, Sailer, Michael, Zettl, Uwe K., Zessack, Norbert, Hartung, Hans-Peter, Gold, Ralf
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251902/
https://ncbi.nlm.nih.gov/pubmed/22276072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285611428503
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars